Bridgeway Capital Management’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-63,800
| Closed | -$542K | – | 1201 |
|
|
2024
Q3 | $542K | Sell |
63,800
-85,000
| -57% | -$723K | 0.01% | 844 |
|
|
2024
Q2 | $695K | Sell |
148,800
-25,000
| -14% | -$117K | 0.02% | 789 |
|
|
2024
Q1 | $1.18M | Sell |
173,800
-20,000
| -10% | -$136K | 0.02% | 699 |
|
|
2023
Q4 | $649K | Buy |
193,800
+50,000
| +35% | +$168K | 0.01% | 873 |
|
|
2023
Q3 | $358K | Buy |
143,800
+25,000
| +21% | +$62.3K | 0.01% | 972 |
|
|
2023
Q2 | $152K | Hold |
118,800
| – | – | ﹤0.01% | 1187 |
|
|
2023
Q1 | $96.4K | Buy |
118,800
+60,000
| +102% | +$48.7K | ﹤0.01% | 1244 |
|
|
2022
Q4 | $44.7K | Sell |
58,800
-50,000
| -46% | -$38K | ﹤0.01% | 1307 |
|
|
2022
Q3 | $101K | Buy |
108,800
+50,000
| +85% | +$46.4K | ﹤0.01% | 1262 |
|
|
2022
Q2 | $56K | Sell |
58,800
-50,000
| -46% | -$47.6K | ﹤0.01% | 1275 |
|
|
2022
Q1 | $230K | Buy |
+108,800
| New | +$230K | ﹤0.01% | 1147 |
|